From: De novo dyspareunia after pelvic organ prolapse surgery
Author | n | Type of surgery | Follow-up | Stages and compartments of women with POP | Outcome | De novo dyspareunia | Erosion/extrusion | |
---|---|---|---|---|---|---|---|---|
Months | Percent | |||||||
Kobashi (2005) | 73 | Site-specific repair reinforced with cadaveric fascia lata | 13.7 | 85 | Symptomatic posterior vaginal wall descent | History, questionnaire | 10% | nm |
Ross (2008) | 48 | Endopelvic porcine dermal implants | 5Â years | 79 | Stage 2 or greater anterior/posterior vaginal wall prolapse | Symptoms | 5% ant. | 2% |
59 | 75 | Pelvic symptom index | 11% post. | Â | ||||
Mechia (2007) | 206 | Anterior vaginal repair vs anterior repair with Pelvicol implant | 12 | 98 | Anterior vaginal wall prolapse stage ≥II | Symptoms | 15% | 0.5% |
10% | Â | |||||||
Dwyer (2004) | 97 | Anterior or posterior repair plus | 29 | Â | Posterior vaginal prolapse | History, questionnaire | 5% | 9% |
Atrium mesh | 9/97 | |||||||
Milani (2005) | 63 | Anterior or posterior repair plus | 17 | – | Anterior or posterior vaginal wall prolapse | History, questionnaire | 20% ant. | 13% anterior |
Prolene mesh | 63% post. | 6.5% posterior | ||||||
Deffieux (2007) | 138 | Cystocele repair polypropylene mesh (Gynemesh) | 32 |  | Anterior vaginal wall prolapse stage ≥II | Symptoms | 9% | 20% |
11% (with mesh erosion) | ||||||||
De Tayrac (2007) | 143 | Cystocele and/or polypropylene mesh | 13 | Â | Anterior and posterior vaginal wall prolapse stage =II | Symptoms | 13% | 6.3% |
PFDI | ||||||||
PFIQ | ||||||||
Natale (2008) | 247 | Cystocele repair with Marlex mesh and high levator myorrhaphy | 60 |  | Vaginal wall prolapse stage ≥II | Symptoms, questionnaires | 9.6% | 8.4% |
Wetta (2009) | 68 | Prolift mesh | 12 |  | Anterior/posterior vaginal wall prolapse stage ≥II | Symptoms, questionnaires | 9% | 2% |
16 anterior | ||||||||
16 posterior | ||||||||
18 total | ||||||||
Lowman (2008) | 129 | Prolift mesh | 6 |  | Vaginal wall prolapse stage ≥II | History, questionnaires | 16.7% | 16.3% |
5.4% anterior | ||||||||
19.4% posterior | ||||||||
75.2% total | ||||||||
Nguyen (2008) | 76 | RCT—cystocele repair polypropylene mesh vs anterior colporrhaphy | 12 |  | Anterior vaginal wall prolapse stage ≥II | Symptoms | 16% (no mesh) | 5% |
9% (with mesh) | ||||||||
Sivaslioglu (2008) | 90 | RCT—cystocele repair polypropylene mesh vs site-specific anterior repair | 12 |  | Anterior vaginal wall prolapse stage ≥II | Symptoms | 0% (no mesh) | 6.9% |
4.6% (with mesh) | ||||||||
Nieminen (2008) | 96 no/vs 104 mesh | Anterior and posterior colporrhaphy vs polypropylene mesh | 24 | 88% and 93% | Anterior vaginal wall prolapse stage ≥II | History, questionnaires | 13% (no mesh) | 8% |
8% (with mesh) | ||||||||
Carey (2009) | 139 | RCT—anterior and posterior colporrhaphy vs polypropylene mesh (Gynemesh) | 12 |  | Vaginal wall prolapse stage ≥II | History, questionnaires | 15.2% (no mesh) | 5.6% |
16.7% (with mesh) |